Corrigendum: The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience - Yan, Ningning; Guo, Sanxing; Huang, Siyuan; Zhang, Huixian; Li, Xingya (Frontiers in Oncology, 2024)